AVTX logo
AVTX NASDAQ US

Avalo Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2015
$17.76
▲ +$1.06 (+6.35%)
Vol 1.1M
4
Quality Score
fail
Mkt Cap
$329.3M
ROE
-88.5%
Margin
-2789.6%
D/E
0.00
Beta
0.85
52W
$3–$21

Wall Street Consensus

17 analysts · Apr 2026
7
Strong Buy
9
Buy
1
Hold
0
Sell
0
Strong Sell
94.1%
Buy Rating

Price Chart

Similar Stocks

ALT
Altimmune Inc
$376.7M
LXEO
Lexeo Therapeutics Inc
$724.8M
AURA
Aura Biosciences Inc
$346.1M
VNDA
Vanda Pharmaceuticals Inc
$521.2M
STRO
Sutro Biopharma Inc
$98.6M
RCKT
Rocket Pharmaceuticals Inc
$379.9M
IPSC
Century Therapeutics Inc
$87.0M

Earnings

Beat rate: 40.0%
Next Report May 11, 2026
EPS Estimate: $-1.07
Quarter EPS Est EPS Act Surprise
Mar 2026 $-1.07 — —
Dec 2025 $-1.49 $-1.13 +$0.36
Sep 2025 $-1.69 $-2.19 $-0.50
Jun 2025 $-1.43 $-1.92 $-0.49

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -48.3% -15.8% -15.8% -15.8% -58.7% -88.5%
P/E (TTM) — — — — — —
Net Margin — -2789.6% -2789.6% -2789.6% -2789.6% -2789.6%
Gross Margin — 242.2% 242.2% 242.2% 242.2% 242.2%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 12.44 12.44 12.44 12.44 14.28 14.28

Key Ratios

ROA (TTM)
-73.9%
P/S (TTM)
746.74
P/B
0.6
EPS (TTM)
$-8.73
CF/Share
$-1.61
Rev Growth 3Y
-56.6%
52W High
$20.72
52W Low
$3.39
$3.39 52-Week Range $20.72

How does AVTX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

AVTX AAPG ABEO ABOS ABP

AVTX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
746.7
▲ 5711% above peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.6
▼ 76% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

AVTX profitability vs Biotechnology peers

ROE
-88.5%
▼ 32% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-2789.6%
▼ 873% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
242.2%
▲ 208% above peers (78.6%)
vs Peers
vs Industry
Below avg
ROA
-73.9%
▼ 58% below peers (-46.7%)
vs Peers
vs Industry
Weak

AVTX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
14.3
▲ 222% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼ 13% below peers (1.0)
vs Peers
vs Industry
Less volatile

AVTX fundamentals radar

AVTX Peer median Industry

AVTX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

AVTX vs peers: key metrics

Latest News

No related news yet